TechCreate Establishes Dominance In Cybersecurity Market Through Strategic Partnerships And Achievements
KUALA LUMPUR, MALAYSIA - Media OutReach - 24 August 2024 - TechCreate, a trusted proprietary…
3 years ago
Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch
Funding from Wellcome will further broaden Vaxxas’ diverse clinical pipeline of next-generation vaccines to include…
3 years ago
Trilliant Focuses on Data and Digitalization as Backbone of Low Carbon Future at Energy Transition Conference, hosted by TNB
Company is a Diamond partner and plenary speaker at the event in Malaysia KUALA LUMPUR,…
3 years ago
TDCX’s Second Quarter 2023 Profit up 9.4%
SINGAPORE--(BUSINESS WIRE)--TDCX Inc. (NYSE: TDCX) (“TDCX†or the “Companyâ€), an award-winning digital customer experience (CX)…
3 years ago
Rayonier Releases 2022 Sustainability Report and Carbon Report
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) today released its 2022 Sustainability Report, which highlights the actions…
3 years ago
Rocket Lab Brings Forward Milestone Recovery Mission
Rocket Lab plans to recover the Electron rocket’s first stage during the Company’s upcoming 40th…
3 years ago
Light & Wonder Announces Successful Completion of Notes Offering
LAS VEGAS--(BUSINESS WIRE)--Light & Wonder, Inc. (NASDAQ and ASX: LNW) (“Light & Wonder†or the…
3 years ago
GARP’s Financial Risk Manager (FRM®) Certification Benchmarked to Master’s Degree Level After Ecctis Reevaluation
FRM Program also now comparable to a master’s degree in Brazil, China, Japan, Mexico, and…
3 years ago
CyberLink Launches FaceMe® Platform 5.4, a Complete API Solution for Facial Recognition
TAIPEI, Taiwan--(BUSINESS WIRE)--CyberLink Corp. (5203.TW), a pioneer in AI and facial recognition technologies, today announced…
3 years ago
Phase 3 Trial Results for Stempeutics Cell Therapy in Knee Osteoarthritis Published in American Journal of Sports Medicine (AJSM)
BENGALURU, India--(BUSINESS WIRE)--#InflammatoryDiseases--Stempeutics, a leader in allogeneic cellular medicines for inflammatory diseases, announced the publication…
3 years ago